Ikarian Capital, LLC PROGENICS PHARMACEUTICALS IN Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
N/A
-130,845 Closed
0 $0
Q4 2019

Jan 31, 2020
BUY
N/A
130,845 New
130,845 $666,000
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email